In silico analysis of the functional implications of drug resistance associated mutations in Mycobacterium tuberculosis
Abstract
The tuberculosis mutation catalogue published by World Health Organization (WHO) lists a large number of mutations based on the statistical significance of their association with resistance or susceptibility to various drugs. However, the mechanism by which they confer resistance to drugs is often not understood. To address these gaps, we combined known resistance associated mutations from the WHO catalogue and newly discovered mutations by explainable artificial intelligence (XAI). In order to decipher the mechanistic basis of drug resistance, we examined where these mutations occur in three dimensional (3D) structures of key drug targets, measured their proximity to drug binding sites and compared their abundance in drug resistant as well as drug susceptible M.tb strains. In parallel, we analyzed the functions of 112 newly identified drug resistance associated genes and compared them to known resistance genes, finding that most novel genes fall into different functional categories, though six share families with known resistance genes. We mapped coding mutations in all 112 novel genes to their functional domains, predicted 3D structures using Alphafold3 and evaluated their effects on protein stability. Notably, our study highlights that mutations in ribosomal proteins (RpsN1, RpsN2) and the transporter PstB may introduce new resistance mechanisms, such as altered drug interactions or increased drug efflux. Whereas, analysis of non coding mutations revealed that most are…
Read the paper
Related studies
- Synthesis, In Vitro and In Silico Molecular Docking Studies of Novel Phthalimide–Pyrimidine Hybrid Analogues to Thalidomide as Potent Antitubercular Agents
- Exploring the inhibitory performance of expired moxifloxacin and norfloxacin on copper corrosion in saline environment
- Molecular investigation of antimicrobial peptides against Helicobacter pylori proteins using a peptide-protein docking approach
- Screening of novel narrow-spectrum benzofuroxan derivatives for the treatment of multidrug-resistant tuberculosis through in silico, in vitro, and in vivo approaches
- Synthesis, Characterization, Anticancer, Antioxidant, and In Silico Evaluation of Semicarbazides and Thiosemicarbazides
- Fast and accurate prediction of drug induced proarrhythmic risk with sex specific cardiac emulators
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.